Quest Diagnostics DGX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 132.4%+1.1pp | 131.3%-2.2pp | 133.4%-12.7pp | 146.1%-14.8pp | |
| Operating margin | 55.9%+2.1pp | 53.8%+2.9pp | 50.9%-21.9pp | 72.9%-21.3pp | |
| Net margin | 35.8%0.0pp | 35.7%+1.7pp | 34.1%-19.1pp | 53.2%-22.8pp | |
| Returns | |||||
| Return on equity | 55.2%+2.5pp | 52.6%+1.3pp | 51.4%-36.3pp | 87.7%-44.0pp | |
| Return on invested capital | 35.9%+1.6pp | 34.3%-1.3pp | 35.7%-21.7pp | 57.4%-19.8pp | |
| Efficiency | |||||
| Asset turnover | 2.7×+0.1× | 2.7×-0.1× | 2.8×-0.3× | 3.1×-0.1× | |
| Liquidity | |||||
| Current ratio | 4.7×+0.4× | 4.3×-0.4× | 4.7×-1.0× | 5.7×-0.7× | |
| Leverage | |||||
| Debt-to-equity | 3.6×0.0× | 3.6×+0.5× | 3.2×+0.2× | 3×+0.1× | |
| Net debt / EBITDA | 12×-0.7× | 12.8×+1.3× | 11.4×+4.4× | 7.1×+2.0× | |
| Valuation | |||||
| Market capitalization | $79.48B+24.1% | $64.06B+5.6% | $60.67B-5.3% | $64.08B-9.7% | |
| Price / earnings | 83.5×+8.1× | 75.4×-0.4× | 75.8×+26.1× | 49.6×+14.9× | |
| Price / sales | 7.5×+0.7× | 6.7×+0.3× | 6.4×+0.2× | 6.2×-0.4× | |
| Price / book | 11.1×+1.5× | 9.6×-0.1× | 9.7×-0.6× | 10.3×-0.8× | |
| EV / EBITDA | 51.1×+1.6× | 49.5×+1.0× | 48.4×+13.1× | 35.4×+6.0× | |
| Dividend yield | 6.9%-1.2pp | 8.1%0.0pp | 8.2%+0.5pp | 7.7%+0.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Quest Diagnostics's profit margins?
- Quest Diagnostics (DGX) runs a 33.2% gross margin and a 14.3% operating margin, with a 9.1% net margin.
- Where do Quest Diagnostics's ratios come from?
- Every ratio is computed from Quest Diagnostics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
